Nexalin Technology (NXL) Inventory (2021 - 2026)
Nexalin Technology's (NXL) quarterly Inventory came in at $179489.0 in Q1 2026, up 2.42% year-on-year from $175253.0 in Q1 2025, and up 36.52% quarter-over-quarter from $131473.0 in Q4 2025.
Nexalin Technology (NXL) Inventory (2021 - 2026) Analysis & Trends
Nexalin Technology's Inventory history runs 6 years deep, the most recent figure standing at $179489.0 for Q1 2026.
- On a quarterly basis, Inventory rose 2.42% year-over-year to $179489.0 in Q1 2026; TTM through Mar 2026 was $179489.0, a 2.42% increase from a year earlier, with the FY2025 full-year figure at $131473.0, down 24.69% from the prior year.
- Inventory improved to $179489.0 in Q1 2026 per NXL's latest filing, from $131473.0 in the prior quarter.
- Across five years, Inventory topped out at $179489.0 in Q1 2026 and bottomed at $131473.0 in Q4 2025.
- The 5-year median for Inventory is $158375.0 (2024), against an average of $159395.5.
- Across the five-year window, Inventory soared 391.47% in 2022 and dropped 24.69% in 2025, its largest moves.
- Year by year, Inventory stood at $154370.0 in 2022, then gained by 1.33% to $156420.0 in 2023, then advanced by 11.61% to $174578.0 in 2024, then retreated by 24.69% to $131473.0 in 2025, then surged by 36.52% to $179489.0 in 2026.
- Per Business Quant, the three latest NXL Inventory figures stand at $179489.0 (Q1 2026), $131473.0 (Q4 2025), and $160225.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.99 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.42 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 5.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 693.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.35 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.12 Bn |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 | 179,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,489.00 |
| Dec 31, 2025 | 131,473.00 |
| Sep 30, 2025 | 160,225.00 |
| Jun 30, 2025 | 172,974.00 |
| Mar 31, 2025 | 175,253.00 |
| Dec 31, 2024 | 174,578.00 |
| Sep 30, 2024 | 158,375.00 |
| Jun 30, 2024 | 145,141.00 |
| Mar 31, 2024 | 153,668.00 |
| Dec 31, 2023 | 156,420.00 |
| Sep 30, 2023 | 158,619.00 |
| Jun 30, 2023 | 160,007.00 |
| Mar 31, 2023 | 158,270.00 |
| Dec 31, 2022 | 154,370.00 |
| Sep 30, 2022 | 152,071.00 |
| Dec 31, 2021 | 31,410.00 |